IRIS Regtech Solutions

Q1 FY22 Earnings Call Analysis

IT - Software

Full Stock Analysis
fundraise: Yescapex: Yesrevenue: Category 3margin: Category 3orderbook: No information
💰

fundraise

Any current/future new fundraising through debt or equity?

- A rights issue is planned to raise equity funding but has been delayed to allow the market to price in recent company performance. - The rights issue will not be priced at a significant discount; it may be at market price or even a premium. - Promoters currently do not have the funds to subscribe to the rights issue. - The rights issue aims to raise capital to support growth in new markets and initiatives, especially related to expanding XBRL reporting opportunities globally. - No mention of specific new debt fundraising; focus is on equity rights issue. - Company expects to generate Rs. 4-5 crores cash next year from operations at current performance levels. - The timing of the rights issue will be decided soon after market conditions stabilize post-earnings call.
🏗️

capex

Any current/future capex/capital investment/strategic investment?

- The company plans to raise funds through a rights issue to support a bigger growth path and new initiatives (Page 6). - The raised capital will be used for growth in certain markets with new opportunities such as expanded XBRL reporting mandates in the US and Europe (Page 6). - No specific current or future capital expenditure amounts are mentioned, but the focus is on strategic investment in market expansion and technology strengthening (Page 18). - The company is also strengthening the technology team significantly, with a very senior technology person joining soon, indicating investment in technology capabilities (Page 18). - Overall, capital investment is geared towards growth, product development, and market expansion rather than heavy physical capex (multiple pages).
📊

revenue

Future growth expectations in sales/revenue/volumes?

- The company expects a natural increase in Annual Recurring Revenue (ARR) next year, factoring in deferred revenues, targeting around Rs. 47 crores for FY23. - They project revenue growth between 10% to 15% without external fundraising, with an adjusted expected growth of 11%-12% when factoring in deferred revenues particularly from South Africa. - Growth is driven primarily by the CREATE segment, which saw a robust 26% growth, and steady growth in the US and European markets, especially through the IRISCARBON SaaS platform. - Revenues have increased at a CAGR of 18% over the last five years, with expenses growing more slowly at 11%, indicating improving operational efficiency. - The company plans to accelerate growth further post rights issue funding and with senior hires in the technology team. - New regulatory mandates and expanding product offerings like ESG filings, IRP (Invoice Registry Portal), and transporter app segments are expected to contribute to revenue growth.
📈

margin

Future growth expectations in earnings/operating earnings/profits/EPS?

- Revenue growth expected between 10%-15% annually without additional funding. - Annual Recurring Revenue (ARR) increased from around Rs. 40 crores to Rs. 47 crores, indicating stable revenue streams. - Deferment of filings in South Africa delayed Rs. 3.25-3.5 crores revenue recognition to next year, likely boosting future revenues. - Rights issue planned to raise capital for growth in new markets and initiatives, potentially accelerating expansion. - Operating costs rose by 18%, including a 12% rise in employee costs, but controlled for efficient spending. - Profitability improving as company cleared employee dues and founders now drawing salaries. - Cash generation projected around Rs. 4-5 crores next year from current operations. - Growth fueled by new mandate opportunities (e.g., US energy market, European ESG filings) and technology enhancements. - Attrition rate around 20%-21%, with talent acquisition stabilizing post funding slowdown in startups.
📋

orderbook

Current/ Expected Orderbook/ Pending Orders?

- The order book mentioned during the call is approximately Rs. 67 crores. - This includes an ARR (Annual Recurring Revenue) component of around Rs. 47 crores for the fiscal year 2023. - The ARR component includes a South Africa component of approximately Rs. 49 crores. - Some contractual components of the order book may spill over into the next financial year. - The company presented the current orders received in their presentation but did not disclose specific current pending orders during the call. - Expansion into some geographies like Chile was mentioned with sales of licenses for SEC filings. - Overall, the order book reflects both recurring revenue and multi-year contracts.